ZOFRASET ondansetron (as hydrochloride dihydrate) 4 mg/2 mL solution for injection pre-filled syringe

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
11-01-2021

Toimeaine:

ondansetron hydrochloride dihydrate, Quantity: 4.99 mg (Equivalent: ondansetron, Qty 4 mg)

Saadav alates:

Accord Healthcare Pty Ltd

Ravimvorm:

Injection, solution

Koostis:

Excipient Ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium hydroxide; water for injections; hydrochloric acid; sodium chloride

Manustamisviis:

Intramuscular, Intravenous

Ühikuid pakis:

Pack of 1 pre-filled syringe

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Ondansetron injection is indicated ? For the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? For the prevention and treatment of post-operative nausea and vomiting.

Toote kokkuvõte:

Visual Identification: Clear, colourless solution in an amber glass pre-filled syringe; Container Type: Syringe; Container Material: Glass Type I Coloured; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Volitamisolek:

Registered

Loa andmise kuupäev:

2020-11-09